445 related articles for article (PubMed ID: 35625618)
21. Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance.
Smith SM; O'Morain C; McNamara D
World J Gastroenterol; 2014 Aug; 20(29):9912-21. PubMed ID: 25110421
[TBL] [Abstract][Full Text] [Related]
22. Strategies used by
Abadi ATB
World J Gastroenterol; 2017 Apr; 23(16):2870-2882. PubMed ID: 28522905
[No Abstract] [Full Text] [Related]
23. Application of proteomics to the study of Helicobacter pylori and implications for the clinic.
Bernardini G; Figura N; Ponzetto A; Marzocchi B; Santucci A
Expert Rev Proteomics; 2017 Jun; 14(6):477-490. PubMed ID: 28513226
[TBL] [Abstract][Full Text] [Related]
24.
Šterbenc A; Jarc E; Poljak M; Homan M
World J Gastroenterol; 2019 Sep; 25(33):4870-4884. PubMed ID: 31543679
[No Abstract] [Full Text] [Related]
25. Comparison of the Diagnostic Performance of qPCR, Sanger Sequencing, and Whole-Genome Sequencing in Determining Clarithromycin and Levofloxacin Resistance in
Egli K; Wagner K; Keller PM; Risch L; Risch M; Bodmer T
Front Cell Infect Microbiol; 2020; 10():596371. PubMed ID: 33392106
[No Abstract] [Full Text] [Related]
26. The Forgotten Virulence Factor: The 'non-conventional' Hemolysin TlyA And Its Role in Helicobacter pylori Infection.
Javadi MB; Katzenmeier G
Curr Microbiol; 2016 Dec; 73(6):930-937. PubMed ID: 27686341
[TBL] [Abstract][Full Text] [Related]
27. Analysis of drug resistance and virulence-factor genotype of Irish Helicobacter pylori strains: is there any relationship between resistance to metronidazole and cagA status?
Taneike I; Nami A; O'Connor A; Fitzgerald N; Murphy P; Qasim A; O'Connor H; O'Morain C
Aliment Pharmacol Ther; 2009 Oct; 30(7):784-90. PubMed ID: 19604178
[TBL] [Abstract][Full Text] [Related]
28. H. pylori infection: bacterial virulence factors and cytokine gene polymorphisms as determinants of infection outcome.
Basso D; Plebani M
Crit Rev Clin Lab Sci; 2004; 41(3):313-37. PubMed ID: 15307635
[TBL] [Abstract][Full Text] [Related]
29.
Muzaheed
ScientificWorldJournal; 2020; 2020():3018326. PubMed ID: 32765194
[No Abstract] [Full Text] [Related]
30. Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic Mutations.
Miftahussurur M; Syam AF; Nusi IA; Makmun D; Waskito LA; Zein LH; Akil F; Uwan WB; Simanjuntak D; Wibawa ID; Waleleng JB; Saudale AM; Yusuf F; Mustika S; Adi P; Maimunah U; Maulahela H; Rezkitha YA; Subsomwong P; Nasronudin ; Rahardjo D; Suzuki R; Akada J; Yamaoka Y
PLoS One; 2016; 11(12):e0166199. PubMed ID: 27906990
[TBL] [Abstract][Full Text] [Related]
31. Medicinal plant activity on Helicobacter pylori related diseases.
Wang YC
World J Gastroenterol; 2014 Aug; 20(30):10368-82. PubMed ID: 25132753
[TBL] [Abstract][Full Text] [Related]
32. Genetic diversity and virulence characteristics of Helicobacter pylori isolates in different human ethnic groups.
Hanafiah A; Lopes BS
Infect Genet Evol; 2020 Mar; 78():104135. PubMed ID: 31837482
[TBL] [Abstract][Full Text] [Related]
33. Helicobacter pylori virulence factors in relation to gastrointestinal diseases in Iran.
Safaralizadeh R; Dastmalchi N; Hosseinpourfeizi M; Latifi-Navid S
Microb Pathog; 2017 Apr; 105():211-217. PubMed ID: 28232251
[TBL] [Abstract][Full Text] [Related]
34. [Helicobacter pylori - 2012].
Buzás GM
Orv Hetil; 2012 Sep; 153(36):1407-18. PubMed ID: 22951408
[TBL] [Abstract][Full Text] [Related]
35. Virulence factors of Helicobacter pylori vacA increase markedly gastric mucosal TGF-β1 mRNA expression in gastritis patients.
Rahimian G; Sanei MH; Shirzad H; Azadegan-Dehkordi F; Taghikhani A; Salimzadeh L; Hashemzadeh-Chaleshtori M; Rafieian-Kopaei M; Bagheri N
Microb Pathog; 2014; 67-68():1-7. PubMed ID: 24462401
[TBL] [Abstract][Full Text] [Related]
36. Influence of Helicobacter pylori virulence factors CagA and VacA on pathogenesis of gastrointestinal disorders.
Nejati S; Karkhah A; Darvish H; Validi M; Ebrahimpour S; Nouri HR
Microb Pathog; 2018 Apr; 117():43-48. PubMed ID: 29432909
[TBL] [Abstract][Full Text] [Related]
37. Analysis of genetic variability, antimicrobial susceptibility and virulence markers in Helicobacter pylori identified in Central Italy.
Cellini L; Grande R; Di Campli E; Di Bartolomeo S; Capodicasa S; Marzio L
Scand J Gastroenterol; 2006 Mar; 41(3):280-7. PubMed ID: 16497614
[TBL] [Abstract][Full Text] [Related]
38. Low clarithromycin resistance in virulent Helicobacter pylori from dyspeptic patients at a tertiary care centre in Odisha.
Hallur V; Panigrahi M; Sable M; Ghosh M; Mohanty S; Purkait S; Praharaj A
Indian J Med Microbiol; 2022; 40(2):211-216. PubMed ID: 35346525
[TBL] [Abstract][Full Text] [Related]
39. Genotyping and antimicrobial resistance patterns of Helicobacter pylori in human and dogs associated with A2142G and A2143G point mutations in clarithromycin resistance.
Hamza D; Elhelw R; Elhariri M; Ragab E
Microb Pathog; 2018 Oct; 123():330-338. PubMed ID: 30031039
[TBL] [Abstract][Full Text] [Related]
40. Cancer-related genetic variants of Helicobacter pylori strains determined using gastric wash-based whole-genome analysis with single-molecule real-time technology.
Watanabe Y; Oikawa R; Kodaka Y; Sato Y; Ono S; Kenmochi T; Suzuki H; Futagami S; Kato M; Yamamoto H; Itoh F
Int J Cancer; 2021 Jan; 148(1):178-192. PubMed ID: 32803883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
